SARS-CoV-2 prophylactic vaccine (Aeterna Zentaris)

N/A

Report date: 2025/01/26 16:18:17

Base Information

Drug NameSARS-CoV-2 prophylactic vaccine (Aeterna Zentaris)
Drug Alias NameSalmonella Typhi Ty21a based recombinant bacterial vaccine (Julius-Maximilians-University Wuerzburg)SARS-CoV-2 prophylactic vaccine (Julius-Maximilians-University Wuerzburg)
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Hospital of Wurzburg
China Registration ClassN/A

Develop Information

Active CompaniesCOSCIENS Biopharma Inc
Inactive CompaniesUniversity Hospital of Wurzburg
Active IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A